Structured treatment interruption for patients with human immunodeficiency virus infection

被引：0
|
作者：
Agut, H [1 ]
机构：
[1] Grp Hosp Pitie Salpetriere, F-75013 Paris, France
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2003年 / 349卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2268 / 2268
页数：1
相关论文
共 50 条
  • [21] Treatment outcome of tuberculosis patients diagnosed with human immunodeficiency virus infection in Iran
    Tabarsi, P.
    Baghaei, P.
    Amiri, M.
    Emami, H.
    Mansouri, D.
    Masjedi, M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S455 - S455
  • [22] Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection
    Jacobson, JM
    Spritzler, J
    Fox, L
    Fahey, JL
    Jackson, JB
    Chernoff, M
    Wohl, DA
    Wu, AW
    Hooton, TM
    Sha, BE
    Shikuma, CM
    MacPhail, LA
    Simpson, DM
    Trapnell, CB
    Basgoz, N
    JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (01): : 61 - 67
  • [23] Treatment outcome of tuberculosis patients diagnosed with human immunodeficiency virus infection in Iran
    Tabarsi, Payam
    Baghaei, Parvaneh
    Mirsaeidi, Mehdi
    Amiri, Majid
    Alipanah, Narges
    Emami, Habib
    Novin, Atieh
    Mansouri, Davood
    Masjedi, Mohammad R.
    Velayati, Ali A.
    SAUDI MEDICAL JOURNAL, 2008, 29 (01) : 148 - 150
  • [24] Integrase inhibitors: A new treatment option for patients with human immunodeficiency virus infection
    Correll, Todd
    Klibanov, Olga M.
    PHARMACOTHERAPY, 2008, 28 (01): : 90 - 101
  • [25] Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection
    Jacobson, JM
    Greenspan, JS
    Spritzler, J
    Ketter, N
    Fahey, JL
    Jackson, JB
    Fox, L
    Chernoff, M
    Wu, AW
    MacPhail, LA
    Vasquez, GJ
    Wohl, DA
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (21): : 1487 - 1493
  • [26] Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection
    Frost, SDW
    Martinez-Picado, J
    Ruiz, L
    Clotet, B
    Brown, AJL
    JOURNAL OF VIROLOGY, 2002, 76 (03) : 968 - 979
  • [27] Verrucous herpes virus infection in human immunodeficiency virus patients
    Fagan, WA
    Collins, PC
    Pulitzer, DR
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1996, 120 (10) : 956 - 958
  • [28] Mycobacterium xenopi infection in patients with human immunodeficiency virus infection
    ElHelou, P
    Rachlis, A
    Fong, I
    Walmsley, S
    Phillips, A
    Salit, I
    Simor, AE
    CLINICAL INFECTIOUS DISEASES, 1997, 25 (02) : 206 - 210
  • [29] Protease inhibitors for the treatment of human immunodeficiency virus infection
    Kakuda, TN
    Struble, KA
    Piscitelli, SC
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (03) : 233 - 254
  • [30] Preventive treatment in human immunodeficiency virus infection: Vaccinations
    Bartlett, JG
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1996, 5 (01) : 25 - 28
12345